Publication | Closed Access
EORTC Melanoma Group. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.
111
Citations
0
References
2008
Year
Surgical OncologyEortc Melanoma GroupMedicineEortc 18991MelanomaImmunologyClinical TrialsCancer TreatmentOncologyRadiation OncologyFinal ResultsHealth Sciences
No additional data available for this publication yet. Check back later!